Misalignment Between Research Hypotheses and Statistical Hypotheses: A Threat to Evidence-Based Medicine?

被引:0
作者
Insa Lawler
Georg Zimmermann
机构
[1] University of North Carolina at Greensboro,Department of Philosophy
[2] Paracelsus Medical University,Department of Neurology, Christian Doppler Medical Centre
[3] Paris Lodron University of Salzburg,Department of Mathematics
[4] Paracelsus Medical University,Spinal Cord Injury and Tissue Regeneration Centre Salzburg
来源
Topoi | 2021年 / 40卷
关键词
Research hypotheses; Statistical hypothesis testing; Null hypotheses; Evidence-based medicine; Clinical decision making;
D O I
暂无
中图分类号
学科分类号
摘要
Evidence-based medicine frequently uses statistical hypothesis testing. In this paradigm, data can only disconfirm a research hypothesis’ competitors: One tests the negation of a statistical hypothesis that is supposed to correspond to the research hypothesis. In practice, these hypotheses are often misaligned. For instance, directional research hypotheses are often paired with non-directional statistical hypotheses. Prima facie, one cannot gain proper evidence for one’s research hypothesis employing a misaligned statistical hypothesis. This paper sheds lights on the nature of and the reasons for such misalignments and it provides a thorough analysis of whether they pose a threat to evidence-based medicine. The upshots are that the misalignments are often hidden for clinicians and that although some cases of misalignments can be partially counterbalanced, the overall threat is non-negligible. The counterbalances either lead to methodological inadequacy (in addition to the misalignment), loss of statistical power, or involve a (potential) lack of information that could be crucial for decision making. This result casts doubt on various findings of medical studies in addition to issues associated with under-powered studies or the replication crisis.
引用
收藏
页码:307 / 318
页数:11
相关论文
共 60 条
  • [1] Bariani G(2015)Sample size calculation in oncology trials: quality of reporting and implications for clinical cancer research Am J Clin Oncol 38 570-574
  • [2] de Celis Ferrari A(2018)Redefine statistical significance Nat Hum Behav 2 6-10
  • [3] Precivale M(1987)Testing a point null hypothesis: the irreconcilability of P values and evidence J Am Stat Assoc 82 62-71
  • [4] Arai R(2017)Can testing clinical significance reduce false positive rates in randomized controlled trials? A snap review BMC Res Notes 10 775-301
  • [5] Saad E(1975)On splitting the tails unequally: a new perspective on one- versus two-tailed tests Educ Psychol Meas 32 283-111
  • [6] Riechelmann R(1987)Reconcilling bayesian and frequentist evidence in the one-sided testing problem J Am Stat Assoc 82 106-1266
  • [7] Benjamin D(2013)Is two-tailed testing for directional research hypotheses tests legitimate? J Bus Res 66 1261-1003
  • [8] Berger J(1994)The earth is round (P Am Psychol 49 997-16
  • [9] Sellke T(2014) .05) R Soc Open Sci 1 1-865
  • [10] Bigirumurame T(2015)An investigation of the false discovery rate and the misinterpretation of P-values Spinal Cord 53 850-347